Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting RIG-I-like receptor pathway for cancer immunotherapy. | J Hematol Oncol | 2023 | 36755342 | PubTator, text mining | PubMed |
| Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation. | Lab Invest | 2023 | 36748193 | PubTator, text mining | PubMed |
| Upregulation of miRNA-10a-5p promotes tumor progression in cervical cancer by suppressing UBE2I signaling. | J Obstet Gynaecol | 2023 | 36744815 | PubTator, text mining | PubMed |
| SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation. | J Proteome Res | 2023 | 36723483 | PubTator, text mining | PubMed |
| Sumoylation is Largely Dispensable for Normal Growth but Facilitates Heat Tolerance in Yeast. | Mol Cell Biol | 2023 | 36720466 | PubTator, text mining | PubMed |
| Joint estimation and imputation of variant functional effects using high throughput assay data. | medRxiv | 2023 | 36711907 | PubTator, text mining | PubMed |
| SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression. | Sci Adv | 2023 | 36706181 | PubTator, text mining | PubMed |
| SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses. | Mol Cell | 2023 | 36702126 | PubTator, text mining | PubMed |
| Transportin 1 is a major nuclear import receptor of the nitric oxide synthase interacting protein. | J Biol Chem | 2023 | 36690276 | PubTator, text mining | PubMed |
| SPRTN patient variants cause global-genome DNA-protein crosslink repair defects. | Nat Commun | 2023 | 36681662 | PubTator, text mining | PubMed |
| The SUMOylation Pathway Components Are Required for Vegetative Growth, Asexual Development, Cytotoxic Responses, and Programmed Cell Death Events in Fusarium oxysporum f. sp. niveum. | J Fungi (Basel) | 2023 | 36675915 | PubTator, text mining | PubMed |
| Extracellular Vesicles Are Important Mediators That Regulate Tumor Lymph Node Metastasis via the Immune System. | Int J Mol Sci | 2023 | 36674900 | PubTator, text mining | PubMed |
| A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3. | Int J Mol Sci | 2023 | 36674743 | PubTator, text mining | PubMed |
| DNA Damage Response and Repair in Boron Neutron Capture Therapy. | Genes (Basel) | 2023 | 36672868 | PubTator, text mining | PubMed |
| The Nuclear Transporter Importin 13 Can Regulate Stress-Induced Cell Death through the Clusterin/KU70 Axis. | Cells | 2023 | 36672214 | PubTator, text mining | PubMed |
| A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules. | Chem Rev | 2023 | 36662637 | PubTator, text mining | PubMed |
| The roles of connexins and gap junctions in the progression of cancer. | Cell Commun Signal | 2023 | 36639804 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules. | Theranostics | 2023 | 36632221 | PubTator, text mining | PubMed |
| UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. | J Clin Invest | 2023 | 36626227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=17